Lütjohann D
Department of Clinical Pharmacology, University of Bonn, Germany.
Acta Neurol Scand Suppl. 2006;185:33-42. doi: 10.1111/j.1600-0404.2006.00683.x.
During the last three to four decades there has been an increasing interest in the interaction of circulating and brain cholesterol. Recent in vivo and in vitro studies have furthered our knowledge of cholesterol metabolism in the central nervous system (CNS). As the CNS matures and cholesterol pools in the brain become constant, the rate of de novo synthesis of cholesterol in the brain markedly declines. Besides some excretion of apoE-bound cholesterol via the CSF, another quantitatively more important mechanism has been described - the conversion of cholesterol into 24S-hydroxycholesterol, that is, in contrast to cholesterol, able to traverse the blood-brain barrier (BBB). The enzyme (CYP46a1) mediating this conversion has been characterized at the molecular level and is mainly located in neurons. Like other oxysterols, 24S-hydroxycholesterol is efficiently converted into normal bile acids or excreted in bile in its sulfated and glucuronidated form. Within the last 10 years the interest in studying the mechanisms of this and other cholesterol transport systems has increased and the results from these in vivo and in vitro investigations are reviewed.
在过去的三四十年里,人们对循环胆固醇与脑胆固醇之间的相互作用越来越感兴趣。最近的体内和体外研究增进了我们对中枢神经系统(CNS)胆固醇代谢的了解。随着中枢神经系统的成熟以及脑内胆固醇池变得恒定,脑内胆固醇的从头合成速率显著下降。除了通过脑脊液排出一些与载脂蛋白E结合的胆固醇外,还描述了另一种在数量上更重要的机制——胆固醇转化为24S-羟基胆固醇,也就是说,与胆固醇不同,24S-羟基胆固醇能够穿过血脑屏障(BBB)。介导这种转化的酶(CYP46a1)已在分子水平上得到表征,且主要位于神经元中。与其他氧化甾醇一样,24S-羟基胆固醇能有效地转化为正常胆汁酸或以其硫酸化和葡萄糖醛酸化形式随胆汁排出。在过去10年里,研究这种及其他胆固醇转运系统机制的兴趣有所增加,本文将对这些体内和体外研究的结果进行综述。